Skip to main content
. 2022 May 3;23:100462. doi: 10.1016/j.lanwpc.2022.100462

Figure 3.

Fig 3

Projection of HIV epidemic trend among Chinese MSM from 2022 to 2052. (a) new infections; (b) new drug-resistant infections; (c) proportion of drug-resistant infections in new infections; (d) HIV/AIDS prevalence; (e) HIV-related death among diagnosed and treated. PrEP pre-exposure prophylaxis; ART antiretroviral therapy.